AllianceBernstein’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-111,520
| Closed | -$515K | – | 3234 |
|
|
2019
Q1 | $515K | Buy |
111,520
+5,800
| +5% | +$26.8K | ﹤0.01% | 2505 |
|
|
2018
Q4 | $370K | Hold |
105,720
| – | – | ﹤0.01% | 2608 |
|
|
2018
Q3 | $1.07M | Hold |
105,720
| – | – | ﹤0.01% | 2288 |
|
|
2018
Q2 | $765K | Buy |
105,720
+19,200
| +22% | +$139K | ﹤0.01% | 2424 |
|
|
2018
Q1 | $523K | Buy |
86,520
+11,900
| +16% | +$71.9K | ﹤0.01% | 2503 |
|
|
2017
Q4 | $718K | Buy |
74,620
+6,600
| +10% | +$63.5K | ﹤0.01% | 2427 |
|
|
2017
Q3 | $604K | Sell |
68,020
-72,820
| -52% | -$647K | ﹤0.01% | 2493 |
|
|
2017
Q2 | $1.78M | Buy |
140,840
+79,220
| +129% | +$1M | ﹤0.01% | 1925 |
|
|
2017
Q1 | $648K | Buy |
61,620
+9,400
| +18% | +$98.9K | ﹤0.01% | 2425 |
|
|
2016
Q4 | $480K | Sell |
52,220
-105,330
| -67% | -$968K | ﹤0.01% | 2551 |
|
|
2016
Q3 | $1.86M | Buy |
157,550
+96,430
| +158% | +$1.14M | ﹤0.01% | 1827 |
|
|
2016
Q2 | $791K | Buy |
61,120
+2,150
| +4% | +$27.8K | ﹤0.01% | 2327 |
|
|
2016
Q1 | $943K | Buy |
58,970
+11,150
| +23% | +$178K | ﹤0.01% | 2127 |
|
|
2015
Q4 | $1.37M | Hold |
47,820
| – | – | ﹤0.01% | 1912 |
|
|
2015
Q3 | $1.36M | Sell |
47,820
-9,480
| -17% | -$270K | ﹤0.01% | 1954 |
|
|
2015
Q2 | $2.06M | Buy |
57,300
+9,900
| +21% | +$356K | ﹤0.01% | 1765 |
|
|
2015
Q1 | $1.38M | Sell |
47,400
-1,600
| -3% | -$46.5K | ﹤0.01% | 1995 |
|
|
2014
Q4 | $1.03M | Sell |
49,000
-11,200
| -19% | -$236K | ﹤0.01% | 2183 |
|
|
2014
Q3 | $1.17M | Sell |
60,200
-11,600
| -16% | -$225K | ﹤0.01% | 2090 |
|
|
2014
Q2 | $1.12M | Sell |
71,800
-1,300,564
| -95% | -$20.3M | ﹤0.01% | 2166 |
|
|
2014
Q1 | $28.4M | Buy |
1,372,364
+1,353,950
| +7,353% | +$28M | 0.02% | 601 |
|
|
2013
Q4 | $238K | Buy |
18,414
+16,200
| +732% | +$209K | ﹤0.01% | 2734 |
|
|
2013
Q3 | $26K | Sell |
2,214
-1,572
| -42% | -$18.5K | ﹤0.01% | 3073 |
|
|
2013
Q2 | $17K | Buy |
+3,786
| New | +$17K | ﹤0.01% | 3073 |
|